New Therapeutic Targets for Cancer: The Interplay Between Immune and Metabolic Checkpoints and Gut Microbiota

Clinical and Translational Medicine - United Kingdom
doi 10.1186/s40169-019-0241-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Corrigendum: Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets

Frontiers in Genetics
GeneticsMolecular Medicine
2019English

Role of Vitamin D in the Hygiene Hypothesis: The Interplay Between Vitamin D, Vitamin D Receptors, Gut Microbiota, and Immune Response

Frontiers in Immunology
AllergyImmunology
2016English

The Rise of NK Cell Checkpoints as Promising Therapeutic Targets in Cancer Immunotherapy

Frontiers in Immunology
AllergyImmunology
2019English

An Update on the Role of Gut Microbiota in Chronic Inflammatory Diseases, and Potential Therapeutic Targets

Expert Review of Gastroenterology and Hepatology
HepatologyGastroenterology
2018English

Crosstalk Between the Gut Microbiome and Bioactive Lipids: Therapeutic Targets in Cognitive Frailty

Frontiers in Nutrition
NutritionDieteticsFood ScienceEndocrinologyMetabolismDiabetes
2020English

The Microbiota and Immune‐mediated Diseases: Opportunities for Therapeutic Intervention

European Journal of Immunology
AllergyImmunology
2020English

Gut Microbiota-Immune System Crosstalk and Pancreatic Disorders

Mediators of Inflammation
ImmunologyCell Biology
2018English

Manipulating Gut Microbiota Composition to Enhance the Therapeutic Effect of Cancer Immunotherapy

Integrative Cancer Therapies
OncologyAlternative MedicineComplementary
2019English

Gut Microbiota, Fusobacteria, and Colorectal Cancer

Diseases
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy